Detalhe da pesquisa
1.
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.
Brain
; 146(2): 668-677, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857854
2.
Impact of the COVID-19 pandemic on hospitalizations of patients with moderate-to-severe skin diseases: A retrospective cohort analysis from a Central European Center.
J Am Acad Dermatol
; 86(1): 245-248, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34560193
3.
Effectiveness of IT-supported patient recruitment: study protocol for an interrupted time series study at ten German university hospitals.
Trials
; 25(1): 125, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365848
4.
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
Int J Radiat Oncol Biol Phys
; 118(5): 1282-1293, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914144
5.
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
JAMA Pediatr
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587854
6.
Primate liver tissue substrate in indirect immunofluorescence diagnostics for patients with dermatitis herpetiformis and celiac disease.
Front Immunol
; 14: 1104360, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875085
7.
Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy.
JAMA Netw Open
; 6(2): e230090, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808242
8.
Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study.
J Neuromuscul Dis
; 10(1): 29-40, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36565133
9.
Additive Intralesional Interleukin-2 Improves Progression-Free Survival in a Distinct Subgroup of Melanoma Patients with Prior Progression under Immunotherapy.
Cancers (Basel)
; 14(3)2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158808
10.
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.
Orphanet J Rare Dis
; 17(1): 384, 2022 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36274155